The Manufacturers Life Insurance Company Sells 276 Shares of Chemed Co. (NYSE:CHE)

The Manufacturers Life Insurance Company trimmed its position in shares of Chemed Co. (NYSE:CHE) by 2.2% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 12,331 shares of the company’s stock after selling 276 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Chemed were worth $6,533,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Raymond James Financial Inc. bought a new stake in Chemed during the 4th quarter worth approximately $42,023,000. Signal Advisors Wealth LLC boosted its stake in Chemed by 60.7% in the fourth quarter. Signal Advisors Wealth LLC now owns 4,995 shares of the company’s stock worth $2,647,000 after purchasing an additional 1,886 shares in the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of Chemed by 10.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 136,182 shares of the company’s stock worth $72,149,000 after purchasing an additional 13,394 shares during the last quarter. Bright Rock Capital Management LLC acquired a new stake in shares of Chemed in the fourth quarter valued at $1,060,000. Finally, Fifth Third Bancorp raised its holdings in shares of Chemed by 12.1% in the fourth quarter. Fifth Third Bancorp now owns 4,934 shares of the company’s stock valued at $2,614,000 after buying an additional 531 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Stock Down 0.0 %

Shares of CHE opened at $576.00 on Wednesday. The stock’s fifty day simple moving average is $590.41 and its 200-day simple moving average is $565.56. The firm has a market capitalization of $8.43 billion, a PE ratio of 29.11, a price-to-earnings-growth ratio of 2.15 and a beta of 0.59. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $623.61.

Chemed (NYSE:CHE) last issued its earnings results on Wednesday, April 23rd. The company reported $5.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.59 by $0.04. The company had revenue of $646.94 million for the quarter, compared to analyst estimates of $641.78 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The company’s revenue for the quarter was up 9.8% on a year-over-year basis. During the same quarter last year, the firm earned $5.20 EPS. Analysts anticipate that Chemed Co. will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. The ex-dividend date of this dividend was Monday, February 24th. Chemed’s dividend payout ratio (DPR) is currently 9.74%.

Analysts Set New Price Targets

CHE has been the subject of several research reports. Royal Bank of Canada raised their price objective on shares of Chemed from $667.00 to $674.00 and gave the company an “outperform” rating in a research report on Monday, April 28th. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th.

Insider Activity at Chemed

In related news, CEO Kevin J. Mcnamara sold 1,000 shares of the business’s stock in a transaction on Monday, March 31st. The shares were sold at an average price of $615.33, for a total transaction of $615,330.00. Following the transaction, the chief executive officer now directly owns 101,679 shares in the company, valued at approximately $62,566,139.07. The trade was a 0.97 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have sold 4,500 shares of company stock worth $2,667,345 in the last ninety days. Company insiders own 3.29% of the company’s stock.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.